Literature DB >> 16395444

Cucurbit[n]uril binding of platinum anticancer complexes.

Nial J Wheate1, Damian P Buck, Anthony I Day, J Grant Collins.   

Abstract

The encapsulation of cisplatin by cucurbit[7]uril (Q[7]) and multinuclear platinum complexes linked via a 4,4'-dipyrazolylmethane (dpzm) ligand by Q[7] and cucurbit[8]uril (Q[8]) has been studied by NMR spectroscopy and molecular modelling. The NMR studies suggest that some cisplatin binds in the cucurbituril cavity, while cis-[PtCl(NH3)2(H2O)]+ only binds at the portals. Alternatively, the dpzm-linked multinuclear platinum complexes are quantitatively encapsulated within the cavities of both Q[7] and Q[8]. Upon encapsulation, the non-exchangeable proton resonances of the multinuclear platinum complexes show significant upfield shifts in 1H NMR spectra. The H3/H3* resonances shift upfield by 0.08 to 0.55 ppm, the H5/H5* shift by 0.9 to 1.6 ppm, while the methylene resonances shift by 0.74 to 0.88 ppm. The size of the resonance shift is dependent on the cavity size of the encapsulating cucurbituril, with Q[7] encapsulation producing larger shifts than Q[8]. The upfield shifts of the dpzm resonances observed upon cucurbituril encapsulation indicate that the Q[7] or Q[8] is positioned directly over the dpzm linking ligand. The terminal platinum groups of trans-[{PtCl(NH3)2}2 mu-dpzm]2+ (di-Pt) and trans-[trans-{PtCl(NH3)2}2-trans-{Pt(dpzm)2(NH3)2}]4+ (tri-Pt) provide a barrier to the on and off movement of cucurbituril, resulting in binding kinetics that are slow on the NMR timescale for the metal complex. Although the dpzm ligand has relatively few rotamers, encapsulation by the larger Q[8] resulted in a more compact di-Pt conformation with each platinum centre retracted further into each Q[8] portal. Encapsulation of the hydrolysed forms of di-Pt and tri-Pt is considerably slower than for the corresponding Cl forms, presumably due to the high-energy cost of passing the +2 platinum centres through the cucurbituril portals. The results of this study suggest that cucurbiturils could be suitable hosts for the pharmacological delivery of multinuclear platinum complexes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16395444     DOI: 10.1039/b513197a

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  14 in total

1.  Simulations on the possibility of formation of complexes between fluorouracil drug and cucurbit[n]urils: ab initio van der Waals DFT study.

Authors:  Mahsa Sabet; M Darvish Ganji
Journal:  J Mol Model       Date:  2013-07-13       Impact factor: 1.810

2.  Encapsulation of alkyl and aryl derivatives of quaternary ammonium cations within cucurbit[n]uril (n = 6,7) and their inverted diastereomers: density functional investigations.

Authors:  Ishita A Raja; Vivekanand V Gobre; Rahul V Pinjari; Shridhar P Gejji
Journal:  J Mol Model       Date:  2014-02-25       Impact factor: 1.810

Review 3.  Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.

Authors:  Mahdi Karimi; Parham Sahandi Zangabad; Fatemeh Mehdizadeh; Hedieh Malekzad; Alireza Ghasemi; Sajad Bahrami; Hossein Zare; Mohsen Moghoofei; Amin Hekmatmanesh; Michael R Hamblin
Journal:  Nanoscale       Date:  2017-01-26       Impact factor: 7.790

4.  Recognition-mediated activation of therapeutic gold nanoparticles inside living cells.

Authors:  Chaekyu Kim; Sarit S Agasti; Zhengjiang Zhu; Lyle Isaacs; Vincent M Rotello
Journal:  Nat Chem       Date:  2010-10-03       Impact factor: 24.427

5.  Synthesis and Spectroscopic Investigation of Diketopyrrolopyrrole - Spiropyran Dyad for Fluorescent Switch Application.

Authors:  Siva Doddi; K Narayanaswamy; Bheerappagari Ramakrishna; Surya Prakash Singh; Prakriti Ranjan Bangal
Journal:  J Fluoresc       Date:  2016-08-04       Impact factor: 2.217

6.  Encapsulation of platinum(II)-based DNA intercalators within cucurbit[6,7,8]urils.

Authors:  Sharon Kemp; Nial J Wheate; Shaoyu Wang; J Grant Collins; Stephen F Ralph; Anthony I Day; Vincent J Higgins; Janice R Aldrich-Wright
Journal:  J Biol Inorg Chem       Date:  2007-07-25       Impact factor: 3.358

7.  Cucurbit[7]uril containers for targeted delivery of oxaliplatin to cancer cells.

Authors:  Liping Cao; Gaya Hettiarachchi; Volker Briken; Lyle Isaacs
Journal:  Angew Chem Int Ed Engl       Date:  2013-09-13       Impact factor: 15.336

8.  HYDROPHOBE Challenge: A Joint Experimental and Computational Study on the Host-Guest Binding of Hydrocarbons to Cucurbiturils, Allowing Explicit Evaluation of Guest Hydration Free-Energy Contributions.

Authors:  Khaleel I Assaf; Mara Florea; Jens Antony; Niel M Henriksen; Jian Yin; Andreas Hansen; Zheng-Wang Qu; Rebecca Sure; Dieter Klapstein; Michael K Gilson; Stefan Grimme; Werner M Nau
Journal:  J Phys Chem B       Date:  2017-12-01       Impact factor: 2.991

9.  Cucurbit[6]uril p-xylylenediammonium diiodide deca-hydrate inclusion complex.

Authors:  Wei-Hao Huang; Peter Y Zavalij; Lyle Isaacs
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-06-21

10.  Assessment of the Biocompatibility of Cucurbiturils in Blood Cells.

Authors:  Alina Aktanova; Tatjana Abramova; Ekaterina Pashkina; Olga Boeva; Lyubov Grishina; Ekaterina Kovalenko; Vladimir Kozlov
Journal:  Nanomaterials (Basel)       Date:  2021-05-21       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.